Life Sciences and Stem Special Report

The sector has prospered in from continuing life investment but there are areas that could benefit from further development

Public-private collaboration was critical in the response to Covid-19

New EU rules requiring recertification of medical devices by May 2024 have prompted fears that patient access to medtech may be put at risk

Ireland has evolved into a highly cohesive research and innovation ecosystem

The Irish medtech sector employs 40,000 people but maintaining our global reputation will require action in a number of areas

Demand for the adoption of digital health has accelerated as a result of Covid-19

Ireland’s pharmaceutical industry has seen a steady evolution to a fully integrated sector since it was first established in the 1950s

Yhe continued success in R&D delivering new therapies and treatments will rely on the continued innovation and ingenuity of research conducted by academic institutions/academic partners across Ireland

‘I was the first woman to win that award and all of a sudden I had a huge influx of women applying to work here’

How life sciences companies are leveraging artificial intelligence

Irish firms played crucial roles in national and international response to Covid-19

Why Ireland is an attractive home for the world’s life science companies

Sector employing 50,000 in Ireland leans towards scientific and engineering roles

Agility is important to the sector and valued by professionals who want to progress